Valuation: Alpha IVF Group

Market Cap 1.21B 297M 259M 240M 222M 417M 28.51B 425M 2.86B 1.12B 13.96B 1.11B 1.09B 48.06B P/E 2026 *
21.7x
P/E 2027 * 17.2x
Enterprise Value 1.21B 297M 259M 240M 222M 417M 28.51B 425M 2.86B 1.12B 13.96B 1.11B 1.09B 48.06B EV / Sales 2026 *
5.93x
EV / Sales 2027 * 4.91x
Free-Float
23.4%
Yield 2026 *
4%
Yield 2027 * 4%
1 week+2.04%
Current month+2.04%
1 month+2.04%
3 months-3.85%
6 months-15.25%
Current year-15.25%
1 week 0.24
Extreme 0.245
0.25
1 month 0.24
Extreme 0.24
0.25
Current year 0.24
Extreme 0.235
0.31
1 year 0.24
Extreme 0.235
0.34
3 years 0.24
Extreme 0.235
0.38
5 years 0.24
Extreme 0.235
0.38
10 years 0.24
Extreme 0.235
0.38
Date Insider Type Main position Quantity % Market Cap.
03-17Others

Chief Executive Officer

1,555,200,000 32.0000%
03-17Others

Chief Executive Officer

1,555,200,000 32.0000%
03-15Others

Director

500,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.04%-7.41% - 297M
+1.05%+3.38%+25.56%+0.89% 196B
-6.78%-11.19%-26.52%+7.20% 144B
-0.55%+2.50%+0.66%-17.25% 142B
-4.52%-5.89%-59.14%-19.61% 66.37B
-1.85%-4.99%+15.09%-3.52% 52.85B
-3.57%-2.72%-25.44%-33.65% 45.22B
+0.87%+3.10%+12.59%+12.90% 37.86B
+0.85%+0.39%+23.74%+39.01% 36.64B
-5.59%-4.98%-17.18%-24.64% 29.71B
Average -1.46%-1.63%-5.80%-4.30% 75.12B
Weighted average by Cap. -1.52%-1.27%-2.87%-4.07%

Financials

2026 *2027 *
Net sales 204M 50.01M 43.71M 40.4M 37.33M 70.29M 4.8B 71.57M 482M 189M 2.35B 188M 184M 8.1B 247M 60.46M 52.83M 48.84M 45.12M 84.98M 5.81B 86.52M 582M 229M 2.84B 227M 222M 9.79B
Net income 55.25M 13.55M 11.84M 10.95M 10.11M 19.04M 1.3B 19.39M 131M 51.21M 637M 50.89M 49.77M 2.19B 69.15M 16.96M 14.82M 13.7M 12.66M 23.83M 1.63B 24.27M 163M 64.1M 798M 63.69M 62.29M 2.75B
Net Debt - -
Logo Alpha IVF Group
Alpha IVF Group Bhd is a Malaysia-based fertility science, research, and advancement company. The company engages in the provision of assisted reproductive services through its specialist fertility care centers. The company offers access to comprehensive fertility services, technology, and labs across its fertility centers. Its assisted reproductive technologies (ART) refer to a range of medical technologies and treatments complemented with laboratory technologies and procedures to assist individuals or couples in overcoming the challenges of infertility. The company’s assisted reproductive services (ARS) include support services, such as fertility assessment, diagnostics and testing, monitoring, preconception care, and counseling. The medical technologies and treatments of ART are primarily carried out by medical specialists in obstetrics and gynecology, who are also responsible for the prescription of fertility and other related drugs.
Employees
198
Date Price Change Volume
26-07-14 MYR 0.2500 0.00% 669,500
26-07-13 MYR 0.2500 0.00% 482,900
26-07-10 MYR 0.2500 0.00% 284,100
26-07-09 MYR 0.2500 +2.04% 277,500
26-07-08 MYR 0.2450 0.00% 88,600
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2500MYR
Average target price
0.3500MYR
Spread / Average Target
+40.00%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALPHA Stock